Literature DB >> 30375508

Effects of BDNF Val66Met genotype and schizophrenia familial risk on a neural functional network for cognitive control in humans.

J I Schweiger1, E Bilek1, A Schäfer1, U Braun1, C Moessnang1, A Harneit1, P Post1, K Otto1, N Romanczuk-Seiferth2, S Erk2, C Wackerhagen2, M Mattheisen3,4, T W Mühleisen5,6, S Cichon5,7, M M Nöthen8,9, J Frank10, S H Witt10, M Rietschel10, A Heinz2, H Walter2, A Meyer-Lindenberg1, H Tost11.   

Abstract

Cognitive control represents an essential neuropsychological characteristic that allows for the rapid adaption of a changing environment by constant re-allocation of cognitive resources. This finely tuned mechanism is impaired in psychiatric disorders such as schizophrenia and contributes to cognitive deficits. Neuroimaging has highlighted the contribution of the anterior cingulate cortex (ACC) and prefrontal regions (PFC) on cognitive control and demonstrated the impact of genetic variation, as well as genetic liability for schizophrenia. In this study, we aimed to examine the influence of the functional single-nucleotide polymorphism (SNP) rs6265 of a plasticity-related neurotrophic factor gene, BDNF (Val66Met), on cognitive control. Strong evidence implicates BDNF Val66Met in neural plasticity in humans. Furthermore, several studies suggest that although the variant is not convincingly associated with schizophrenia risk, it seems to be a modifier of the clinical presentation and course of the disease. In order to clarify the underlying mechanisms using functional magnetic resonance imaging (fMRI), we studied the effects of this SNP on ACC and PFC activation, and the connectivity between these regions in a discovery sample of 85 healthy individuals and sought to replicate this effect in an independent sample of 253 individuals. Additionally, we tested the identified imaging phenotype in relation to schizophrenia familial risk in a sample of 58 unaffected first-degree relatives of schizophrenia patients. We found a significant increase in interregional connectivity between ACC and PFC in the risk-associated BDNF 66Met allele carriers. Furthermore, we replicated this effect in an independent sample and demonstrated its independence of structural confounds, as well as task specificity. A similar coupling increase was detectable in individuals with increased familial risk for schizophrenia. Our results show that a key neural circuit for cognitive control is influenced by a plasticity-related genetic variant, which may render this circuit particular susceptible to genetic and environmental risk factors for schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30375508      PMCID: PMC6333795          DOI: 10.1038/s41386-018-0248-9

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  57 in total

1.  Automated Talairach atlas labels for functional brain mapping.

Authors:  J L Lancaster; M G Woldorff; L M Parsons; M Liotti; C S Freitas; L Rainey; P V Kochunov; D Nickerson; S A Mikiten; P T Fox
Journal:  Hum Brain Mapp       Date:  2000-07       Impact factor: 5.038

Review 2.  Genetics of cognitive control: Implications for Nimh's research domain criteria initiative.

Authors:  David C Glahn; Emma E M Knowles; Godfrey D Pearlson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-08-19       Impact factor: 3.568

3.  Individual differences in the bilingual brain: The role of language background and DRD2 genotype in verbal and non-verbal cognitive control.

Authors:  Kelly A Vaughn; Aurora I Ramos Nuñez; Maya R Greene; Brandin A Munson; Elena L Grigorenko; Arturo E Hernandez
Journal:  J Neurolinguistics       Date:  2016-07-18       Impact factor: 1.710

4.  Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A.

Authors:  Roberta Rasetti; Fabio Sambataro; Qiang Chen; Joseph H Callicott; Venkata S Mattay; Daniel R Weinberger
Journal:  Arch Gen Psychiatry       Date:  2011-08-01

5.  Age at onset of psychotic disorder: cannabis, BDNF Val66Met, and sex-specific models of gene-environment interaction.

Authors:  Jeroen Decoster; Jim van Os; Gunter Kenis; Cecile Henquet; Joseph Peuskens; Marc De Hert; Ruud van Winkel
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-02-08       Impact factor: 3.568

6.  Conflict adaptation in prefrontal cortex: now you see it, now you don't.

Authors:  Chobok Kim; Nathan F Johnson; Brian T Gold
Journal:  Cortex       Date:  2013-08-30       Impact factor: 4.027

7.  From maps to mechanisms through neuroimaging of schizophrenia.

Authors:  Andreas Meyer-Lindenberg
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

Review 8.  BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses.

Authors:  Kurt Gottmann; Thomas Mittmann; Volkmar Lessmann
Journal:  Exp Brain Res       Date:  2009-09-24       Impact factor: 1.972

Review 9.  Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions.

Authors:  Jim van Os; Bart Pf Rutten; Richie Poulton
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

10.  Synapses with inhibitory neurons differentiate anterior cingulate from dorsolateral prefrontal pathways associated with cognitive control.

Authors:  Maria Medalla; Helen Barbas
Journal:  Neuron       Date:  2009-02-26       Impact factor: 17.173

View more
  7 in total

1.  Behavioural and functional evidence revealing the role of RBFOX1 variation in multiple psychiatric disorders and traits.

Authors:  Aet O'Leary; Noèlia Fernàndez-Castillo; Gabriela Gan; Yunbo Yang; Anna Y Yotova; Thorsten M Kranz; Lena Grünewald; Florian Freudenberg; Ester Antón-Galindo; Judit Cabana-Domínguez; Anais Harneit; Janina I Schweiger; Kristina Schwarz; Ren Ma; Junfang Chen; Emanuel Schwarz; Marcella Rietschel; Heike Tost; Andreas Meyer-Lindenberg; Christiane A Pané-Farré; Tilo Kircher; Alfons O Hamm; Demian Burguera; Nina Roth Mota; Barbara Franke; Susann Schweiger; Jennifer Winter; Andreas Heinz; Susanne Erk; Nina Romanczuk-Seiferth; Henrik Walter; Andreas Ströhle; Lydia Fehm; Thomas Fydrich; Ulrike Lueken; Heike Weber; Thomas Lang; Alexander L Gerlach; Markus M Nöthen; Georg W Alpers; Volker Arolt; Stephanie Witt; Jan Richter; Benjamin Straube; Bru Cormand; David A Slattery; Andreas Reif
Journal:  Mol Psychiatry       Date:  2022-08-10       Impact factor: 13.437

2.  The brain-derived neurotrophic factor Val66Met polymorphism increases segregation of structural correlation networks in healthy adult brains.

Authors:  Issei Ueda; Kazuhiro Takemoto; Keita Watanabe; Koichiro Sugimoto; Atsuko Ikenouchi; Shingo Kakeda; Asuka Katsuki; Reiji Yoshimura; Yukunori Korogi
Journal:  PeerJ       Date:  2020-08-05       Impact factor: 2.984

Review 3.  Brain-derived neurotrophic factor and schizophrenia.

Authors:  Pasquale Di Carlo; Giovanna Punzi; Gianluca Ursini
Journal:  Psychiatr Genet       Date:  2019-10       Impact factor: 2.574

4.  BDNF Gene's Role in Schizophrenia: From Risk Allele to Methylation Implications.

Authors:  Xiaoqian Fu; Jun Wang; Jianbin Du; Jing Sun; Ancha Baranova; Fuquan Zhang
Journal:  Front Psychiatry       Date:  2020-12-15       Impact factor: 4.157

5.  Association Between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Methamphetamine Use Disorder: A Meta-Analysis.

Authors:  Li He; Yanhui Liao; Qiuxia Wu; Tieqiao Liu
Journal:  Front Psychiatry       Date:  2020-11-19       Impact factor: 4.157

6.  Associations of cognitive impairment in patients with schizophrenia with genetic features and with schizophrenia-related structural and functional brain changes.

Authors:  Chuanjun Zhuo; Hongjun Tian; Jiayue Chen; Qianchen Li; Lei Yang; Qiuyu Zhang; Guangdong Chen; Langlang Cheng; Chunhua Zhou; Xueqin Song
Journal:  Front Genet       Date:  2022-08-19       Impact factor: 4.772

Review 7.  BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review.

Authors:  Rodrigo R Nieto; Andrea Carrasco; Sebastian Corral; Rolando Castillo; Pablo A Gaspar; M Leonor Bustamante; Hernan Silva
Journal:  Front Psychiatry       Date:  2021-06-16       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.